Periacetabular osteotomy versus hip arthroscopy in patients with borderline developmental dysplasia of the hip: A systematic review and multi-level meta-analysis

髋臼周围截骨术与髋关节镜手术治疗边缘性发育性髋关节发育不良患者的疗效比较:系统评价和多水平荟萃分析

阅读:1

Abstract

PURPOSE: A comprehensive meta-analysis is required to address the lack of quantitative evidence on treatment outcomes in borderline developmental dysplasia of the hip (BDDH). This study compares periacetabular osteotomy (PAO) and hip arthroscopy (HAS) through a multi-level meta-analysis, providing quantitative insights into their efficacy and safety. METHODS: A systematic literature search was conducted in PubMed, Epistemonikos, and Embase up to February 28, 2025. A frequentist meta-analysis was performed using the Hartung-Knapp-Sidik-Jonkman heterogeneity estimator. Continuous variables were analyzed using mean values with 95% confidence intervals (CIs), and binary outcomes as proportions with 95% CIs. Sensitivity analysis compared studies defining BDDH as 20-25° versus all included studies. Statistical heterogeneity was assessed using Higgins' I (2). A random-effects model was applied in cases of significant heterogeneity. RESULTS: The literature search identified 39 primary studies with a total of 2075 patients (2121 hips). The test for subgroup differences showed no statistically significant difference between the PAO group and the HAS group in post-operative mHHS (χ (2) = 0.55; df = 1; p = 0.46), in post-operative iHOT-12 (χ (2) = 0.00; df = 1; p = 0.98), in the change in mHHS (χ (2) = 0.37; df = 1; p = 0.54), in the change in iHOT-12 (χ (2) = 1.05; df = 1; p = 0.30), in MCID of post-operative functional outcome scores (χ (2) = 0.43; df = 1; p = 0.51), in reoperation (χ (2) = 0.17; df = 1; p = 0.68), and in complications (χ (2) = 3.35; df = 1; p = 0.07). The absolute mean values for nearly all parameters favour PAO, which may indicate a potential advantage. CONCLUSION: PAO and HAS yield comparable short- to mid-term outcomes in BDDH. Long-term studies are needed to determine whether HAS is a definitive treatment or delays structural correction. Future research should standardize BDDH definitions (LCEA 20-25°) to enhance comparability and treatment consistency. LEVEL OF EVIDENCE: A meta-analysis of retrospective and prospective primary studies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。